Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes (Q33430004)

26 July 2017

Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes (English)

1 reference

26 July 2017

Régis Peffault de Latour

series ordinal

2

object named as

Régis Peffault de Latour

1 reference

26 July 2017

Jean-Hugues Dalle

1

1 reference

26 July 2017

12 February 2016

1 reference

International Journal of Hematology

26 July 2017

1 reference

26 July 2017

103

1 reference

26 July 2017

373-379

1 reference

26 July 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-016-1951-0

26 July 2017

0 references

cites work

Improving diagnostic precision, care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Fanconi anemia and the development of leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Diagnosis of fanconi anemia: mutation analysis by next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Fanconi anemia and solid malignancies in childhood: a national retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Alternative donor hematopoietic cell transplantation for Fanconi anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Excellent outcome of allogeneic bone marrow transplantation for Fanconi anemia using fludarabine-based reduced-intensity conditioning regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Haematopoeitic cell transplantation for Fanconi anaemia - when and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Milestones in umbilical cord blood transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Improving survival for Fanconi anemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Digenic mutations in severe congenital neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

[SFGM-TC recommendation on indications for allogeneic stem cell transplantation in children with congenital neutropenia].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Case Reports of Severe Congenital Neutropenia Treated With Unrelated Cord Blood Transplantation With Reduced-intensity Conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Shwachman-diamond syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Mutations in SBDS are associated with Shwachman-Diamond syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

21 January 2018

Dyskeratosis congenita

1 reference

https://api.crossref.org/works/10.1007%2FS12185-016-1951-0

Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group

21 January 2018

1 reference

12 December 2020

Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning

1 reference

12 December 2020

Bone marrow transplantation for Fanconi anemia.

1 reference

12 December 2020

Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy

1 reference

12 December 2020

Unusual complications after bone marrow transplantation for dyskeratosis congenita

1 reference

12 December 2020

Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantation

1 reference

12 December 2020

Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita

1 reference

12 December 2020

How I treat Diamond-Blackfan anemia

1 reference

12 December 2020

Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome

1 reference

12 December 2020

Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria

1 reference

12 December 2020

Bone marrow transplantation in Fanconi anemia using matched sibling donors

1 reference

12 December 2020

Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French neutropenia register

1 reference

12 December 2020

Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning

1 reference

12 December 2020

Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis

1 reference

12 December 2020

Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan

1 reference

12 December 2020

Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia

1 reference

12 December 2020

Allogeneic stem cell transplantation for patients with acute myeloid leukaemia developing from severe congenital neutropenia

1 reference

12 December 2020

A novel ELANE gene mutation in a patient with severe congenital neutropenia and intermittent thrombocytopenia

1 reference

12 December 2020

Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen

1 reference

12 December 2020

Hematopoietic stem cell transplantation in patients with severe congenital neutropenia: an analysis of 18 Japanese cases

1 reference

12 December 2020

Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation

1 reference

12 December 2020

Game of clones: the genomic evolution of severe congenital neutropenia.

1 reference

12 December 2020

Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.

1 reference

12 December 2020

Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation

1 reference

12 December 2020

Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia

1 reference

12 December 2020

Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation

1 reference

12 December 2020

10.1007/S12185-016-1951-0

Identifiers

DOI

1 reference

PubMed ID

26872907

Dimensions Publication ID

26 July 2017

0 references

1 reference

PubMed ID

26872907